MINIMALLY INVASIVE SURGERY MARKET ANALYSIS

Minimally Invasive Surgery Market, By Device Type (Surgical Devices (Ablation Devices, Electrosurgical Devices, and Medical Robotic Systems), Monitoring & Visualization Devices, and Endoscopy Devices), By Surgery (Orthopedic Surgery, Cosmetic Surgery, Breast Surgery, Vascular Surgery, Thoracic Surgery, Gynecological Surgery, Bariatric Surgery, Cardiac Surgery, Gastrointestinal Surgery, and Urological Surgery) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Global Minimally Invasive Surgery Market- Key Developments

Effective usage of minimally invasive surgery software to treat different diseases is expected to drive the market growth over the forecast period. For instance, in January 2020, according to an article published by JAMA Network, a monthly open access medical journal, in a cohort study of 169,404 patients in 73 hospitals, the usage of robotic surgery for all general surgery procedures has increased from 1.8% to 15.1% from 2012 to 2018.
In December 2022, Abbott, a global healthcare company, announced the launch of its latest-generation transcatheter aortic valve implantation (TAVI) systemnamed Navitor, and thus, made minimally invasive device available to people in India with severe aortic stenosis who are at high or extreme surgical risk.
In December 2021, Integer Holdings Corporation, a leading medical device outsource (MDO) manufacturer, announced the acquisition of Oscor, Inc., a privately-held company that designs, develops, manufactures, and markets a comprehensive portfolio of highly specialized medical devices, venous access systems, and diagnostic catheters, and implantable devices, to develop more devices useful in minimally invasive surgery.
In August 2021, Zimmer Biomet, a global medical technology leader, announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for its ROSA Hip System for robotically-assisted direct anterior total hip replacement.